South Africa is taking no chances.
It’s suspended the rollout of the Johnson & Johnson vaccine.
The decision was taken after six women developed rare blood clotting disorders after having taken the jab in the US.
No cases of blood clotting have been detected in South African healthcare workers who’ve taken the Johnson & Johnson vaccine.
That’s according to co-principal investigator for the Johnson & Johnson trial, Professor Glenda Gray.
Meanwhile…. the South African Medical Association says there’s no need for panic ahead of the temporary suspension of the Johnson and Johnson vaccine in South Africa.
Its head, Dr Angelique Coetzee, says she’s been vaccinated and is not worried as the risk of clotting is low.